RxDoctor Payments Data

Adam Childs, MD

Family Medicine · Murfreesboro, TNNPI 1992978845

Payments from drug & device makers

$9,930in general payments, 2019–2025

Across 595 payments — averaging $16.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Novo Nordisk$1K
  • Pfizer$873
  • AstraZeneca$704
  • GSK$568
  • Otsuka America Pharmaceutical, Inc.$428
  • plus $5K from 54 others

What the payments were for

  • Food & beverage$9,917100%
  • Education$130%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)71$1,211
Novo Nordisk82$1,162
Pfizer56$873
AstraZeneca(2 entities)33$704
GSK37$568
Otsuka America Pharmaceutical, Inc.21$428
Amgen25$394
Boehringer Ingelheim25$382
Takeda Pharmaceuticals U.S.A., Inc.22$331
Lilly USA, LLC21$322
Johnson & Johnson17$302
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC14$225
Bayer12$209
Merck15$201
Nestle Healthcare Nutrition Inc.10$184
Boston Scientific4$176
Novartis10$169
Astellas Pharma US Inc8$154
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)8$139
Dexcom, Inc.7$121
Biohaven Pharmaceutical Holding Company Ltd.5$102
Axsome Therapeutics, Inc.5$99
Exact Sciences6$96
Amarin Pharma, Inc.6$94
E.r. Squibb & Sons, L.L.C.6$88
Impel Pharmaceuticals Inc.4$70
Sanofi-aventis U.S. LLC5$69
Dynavax Technologies Corporation3$59
Agiliti Health, Inc.2$57
Shire North American Group Inc3$57
Antares Pharma, Inc.3$57
Eisai Inc.4$56
Edwards Lifesciences1$53
VBI Vaccine (delaware) Inc.3$46
Inspire Medical Systems, Inc.2$43
Xeris Pharmaceuticals, Inc.3$43
Medtronic2$42
RGH Enterprises LLC1$42
Gilead2$38
Esperion Therapeutics, Inc.2$37
Teva Pharmaceuticals USA, Inc.2$32
Insulet Corporation2$30
Lundbeck LLC2$29
Nalpropion Pharmaceuticals LLC2$28
Idorsia Pharmaceuticals US Inc2$27
Adlon Therapeutics L.p.2$23
Sumitomo Pharma America, Inc.1$20
Agios Pharmaceuticals, Inc.1$20
Hikma Pharmaceuticals USA1$19
Biohaven Pharmaceuticals, Inc.1$18
Aimmune Therapeutics, Inc.1$17
Phathom Pharmaceuticals, Inc.1$16
Daiichi Sankyo Inc.1$16
Sanofi Pasteur Inc.1$16
IBSA Pharma Inc.1$15
Ironwood Pharmaceuticals, Inc1$15
Currax Pharmaceuticals LLC1$14
Phadia US Inc.1$13
Avion Pharmaceuticals1$13
Radius Health, Inc.1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,930 in reported general payments places this provider in the 90th percentile of 2,087 family medicine providers in Tennessee.

See all family medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$38,329
Medicare patients
119
Services billed
818

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide45$60,329
EliquisApixaban48$38,617
MounjaroTirzepatide22$29,034
JanuviaSitagliptin Phosphate19$20,496
Tresiba Flextouch U-200Insulin Degludec18$17,814
Humulin R U-500Insulin Regular, Human11$15,747
XareltoRivaroxaban17$10,346
Tresiba Flextouch U-100Insulin Degludec13$6,441
Novolog FlexpenInsulin Aspart13$3,139
SynthroidLevothyroxine Sodium39$2,701
Albuterol Sulfate HfaAlbuterol Sulfate67$2,248
Omeprazole111$1,915
Rosuvastatin Calcium117$1,861
Gabapentin161$1,769
Ezetimibe31$1,563

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$1,162$60,32945 claims
PfizerEliquis$873$38,61748 claims
Lilly USA, LLCMounjaro$322$29,03422 claims
MerckJanuvia$201$20,49619 claims
Johnson & JohnsonXarelto$302$10,34617 claims
AbbVieSynthroid$1,211$2,70139 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,087 family medicine providers in Tennessee.

Other family medicine in Murfreesboro

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →